nodes	percent_of_prediction	percent_of_DWPC	metapath
Clarithromycin—CYP3A7—Sorafenib—liver cancer	0.124	0.194	CbGbCtD
Clarithromycin—CYP3A7-CYP3A51P—Sorafenib—liver cancer	0.124	0.194	CbGbCtD
Clarithromycin—CYP3A5—Sorafenib—liver cancer	0.0927	0.145	CbGbCtD
Clarithromycin—CYP2C19—Sorafenib—liver cancer	0.0748	0.117	CbGbCtD
Clarithromycin—CYP1A2—Sorafenib—liver cancer	0.069	0.108	CbGbCtD
Clarithromycin—ABCB1—Sorafenib—liver cancer	0.0604	0.0945	CbGbCtD
Clarithromycin—ABCB1—Doxorubicin—liver cancer	0.0366	0.0573	CbGbCtD
Clarithromycin—CYP3A4—Sorafenib—liver cancer	0.0362	0.0566	CbGbCtD
Clarithromycin—CYP3A4—Doxorubicin—liver cancer	0.0219	0.0343	CbGbCtD
Clarithromycin—Candida infection—Doxorubicin—liver cancer	0.000725	0.00288	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000721	0.00287	CcSEcCtD
Clarithromycin—Blood urea increased—Doxorubicin—liver cancer	0.000717	0.00285	CcSEcCtD
Clarithromycin—Vaginal infection—Doxorubicin—liver cancer	0.000717	0.00285	CcSEcCtD
Clarithromycin—Dyspnoea—Sorafenib—liver cancer	0.000706	0.00281	CcSEcCtD
Clarithromycin—Dyspepsia—Sorafenib—liver cancer	0.000697	0.00277	CcSEcCtD
Clarithromycin—Oesophagitis—Doxorubicin—liver cancer	0.000694	0.00276	CcSEcCtD
Clarithromycin—Rash maculo-papular—Doxorubicin—liver cancer	0.00069	0.00274	CcSEcCtD
Clarithromycin—Decreased appetite—Sorafenib—liver cancer	0.000688	0.00274	CcSEcCtD
Clarithromycin—Neoplasm—Doxorubicin—liver cancer	0.000686	0.00273	CcSEcCtD
Clarithromycin—Blood alkaline phosphatase increased—Epirubicin—liver cancer	0.000685	0.00272	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Sorafenib—liver cancer	0.000684	0.00272	CcSEcCtD
Clarithromycin—Fatigue—Sorafenib—liver cancer	0.000683	0.00272	CcSEcCtD
Clarithromycin—Hepatic function abnormal—Epirubicin—liver cancer	0.000681	0.00271	CcSEcCtD
Clarithromycin—Constipation—Sorafenib—liver cancer	0.000677	0.00269	CcSEcCtD
Clarithromycin—Pain—Sorafenib—liver cancer	0.000677	0.00269	CcSEcCtD
Clarithromycin—Hepatic failure—Epirubicin—liver cancer	0.000663	0.00264	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Sorafenib—liver cancer	0.000648	0.00258	CcSEcCtD
Clarithromycin—Blood alkaline phosphatase increased—Doxorubicin—liver cancer	0.000633	0.00252	CcSEcCtD
Clarithromycin—Hepatic function abnormal—Doxorubicin—liver cancer	0.00063	0.00251	CcSEcCtD
Clarithromycin—Urticaria—Sorafenib—liver cancer	0.000629	0.0025	CcSEcCtD
Clarithromycin—Body temperature increased—Sorafenib—liver cancer	0.000626	0.00249	CcSEcCtD
Clarithromycin—Abdominal pain—Sorafenib—liver cancer	0.000626	0.00249	CcSEcCtD
Clarithromycin—Renal impairment—Epirubicin—liver cancer	0.000626	0.00249	CcSEcCtD
Clarithromycin—Dermatitis bullous—Epirubicin—liver cancer	0.000623	0.00248	CcSEcCtD
Clarithromycin—Purpura—Epirubicin—liver cancer	0.000618	0.00246	CcSEcCtD
Clarithromycin—Anaphylactoid reaction—Epirubicin—liver cancer	0.000615	0.00245	CcSEcCtD
Clarithromycin—Hepatic failure—Doxorubicin—liver cancer	0.000613	0.00244	CcSEcCtD
Clarithromycin—Hypoglycaemia—Epirubicin—liver cancer	0.00061	0.00243	CcSEcCtD
Clarithromycin—Hypersensitivity—Sorafenib—liver cancer	0.000583	0.00232	CcSEcCtD
Clarithromycin—Renal impairment—Doxorubicin—liver cancer	0.000579	0.0023	CcSEcCtD
Clarithromycin—Dermatitis bullous—Doxorubicin—liver cancer	0.000576	0.00229	CcSEcCtD
Clarithromycin—Purpura—Doxorubicin—liver cancer	0.000572	0.00227	CcSEcCtD
Clarithromycin—Anaphylactoid reaction—Doxorubicin—liver cancer	0.000569	0.00226	CcSEcCtD
Clarithromycin—Asthenia—Sorafenib—liver cancer	0.000568	0.00226	CcSEcCtD
Clarithromycin—Cardiac arrest—Epirubicin—liver cancer	0.000566	0.00225	CcSEcCtD
Clarithromycin—Hypoglycaemia—Doxorubicin—liver cancer	0.000565	0.00225	CcSEcCtD
Clarithromycin—Pruritus—Sorafenib—liver cancer	0.00056	0.00223	CcSEcCtD
Clarithromycin—Blood creatinine increased—Epirubicin—liver cancer	0.000558	0.00222	CcSEcCtD
Clarithromycin—Liver function test abnormal—Epirubicin—liver cancer	0.00055	0.00219	CcSEcCtD
Clarithromycin—Diarrhoea—Sorafenib—liver cancer	0.000542	0.00216	CcSEcCtD
Clarithromycin—Breast disorder—Epirubicin—liver cancer	0.000538	0.00214	CcSEcCtD
Clarithromycin—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.000536	0.00213	CcSEcCtD
Clarithromycin—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.000536	0.00213	CcSEcCtD
Clarithromycin—Gastritis—Epirubicin—liver cancer	0.000527	0.0021	CcSEcCtD
Clarithromycin—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000525	0.00209	CcSEcCtD
Clarithromycin—Cardiac arrest—Doxorubicin—liver cancer	0.000524	0.00208	CcSEcCtD
Clarithromycin—Dizziness—Sorafenib—liver cancer	0.000524	0.00208	CcSEcCtD
Clarithromycin—Abdominal distension—Epirubicin—liver cancer	0.000518	0.00206	CcSEcCtD
Clarithromycin—Blood creatinine increased—Doxorubicin—liver cancer	0.000516	0.00205	CcSEcCtD
Clarithromycin—Influenza—Epirubicin—liver cancer	0.000515	0.00205	CcSEcCtD
Clarithromycin—Asthma—Epirubicin—liver cancer	0.000515	0.00205	CcSEcCtD
Clarithromycin—Eosinophilia—Epirubicin—liver cancer	0.00051	0.00203	CcSEcCtD
Clarithromycin—Liver function test abnormal—Doxorubicin—liver cancer	0.000509	0.00202	CcSEcCtD
Clarithromycin—Pancreatitis—Epirubicin—liver cancer	0.000505	0.00201	CcSEcCtD
Clarithromycin—Vomiting—Sorafenib—liver cancer	0.000503	0.002	CcSEcCtD
Clarithromycin—Rash—Sorafenib—liver cancer	0.000499	0.00199	CcSEcCtD
Clarithromycin—Dermatitis—Sorafenib—liver cancer	0.000499	0.00198	CcSEcCtD
Clarithromycin—Breast disorder—Doxorubicin—liver cancer	0.000498	0.00198	CcSEcCtD
Clarithromycin—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000496	0.00197	CcSEcCtD
Clarithromycin—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000496	0.00197	CcSEcCtD
Clarithromycin—Headache—Sorafenib—liver cancer	0.000496	0.00197	CcSEcCtD
Clarithromycin—Gastritis—Doxorubicin—liver cancer	0.000488	0.00194	CcSEcCtD
Clarithromycin—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000486	0.00193	CcSEcCtD
Clarithromycin—Dysuria—Epirubicin—liver cancer	0.000481	0.00191	CcSEcCtD
Clarithromycin—Neutropenia—Epirubicin—liver cancer	0.000481	0.00191	CcSEcCtD
Clarithromycin—Abdominal distension—Doxorubicin—liver cancer	0.000479	0.00191	CcSEcCtD
Clarithromycin—Influenza—Doxorubicin—liver cancer	0.000476	0.00189	CcSEcCtD
Clarithromycin—Asthma—Doxorubicin—liver cancer	0.000476	0.00189	CcSEcCtD
Clarithromycin—Eosinophilia—Doxorubicin—liver cancer	0.000471	0.00188	CcSEcCtD
Clarithromycin—Nausea—Sorafenib—liver cancer	0.00047	0.00187	CcSEcCtD
Clarithromycin—Pancreatitis—Doxorubicin—liver cancer	0.000467	0.00186	CcSEcCtD
Clarithromycin—Pneumonia—Epirubicin—liver cancer	0.000462	0.00184	CcSEcCtD
Clarithromycin—Infestation NOS—Epirubicin—liver cancer	0.000459	0.00183	CcSEcCtD
Clarithromycin—Infestation—Epirubicin—liver cancer	0.000459	0.00183	CcSEcCtD
Clarithromycin—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000455	0.00181	CcSEcCtD
Clarithromycin—Renal failure—Epirubicin—liver cancer	0.000451	0.00179	CcSEcCtD
Clarithromycin—Jaundice—Epirubicin—liver cancer	0.000447	0.00178	CcSEcCtD
Clarithromycin—Stomatitis—Epirubicin—liver cancer	0.000447	0.00178	CcSEcCtD
Clarithromycin—Conjunctivitis—Epirubicin—liver cancer	0.000446	0.00177	CcSEcCtD
Clarithromycin—Neutropenia—Doxorubicin—liver cancer	0.000445	0.00177	CcSEcCtD
Clarithromycin—Dysuria—Doxorubicin—liver cancer	0.000445	0.00177	CcSEcCtD
Clarithromycin—Haematuria—Epirubicin—liver cancer	0.000437	0.00174	CcSEcCtD
Clarithromycin—Hepatobiliary disease—Epirubicin—liver cancer	0.000434	0.00173	CcSEcCtD
Clarithromycin—Epistaxis—Epirubicin—liver cancer	0.000433	0.00172	CcSEcCtD
Clarithromycin—Agranulocytosis—Epirubicin—liver cancer	0.000428	0.0017	CcSEcCtD
Clarithromycin—Pneumonia—Doxorubicin—liver cancer	0.000427	0.0017	CcSEcCtD
Clarithromycin—Infestation NOS—Doxorubicin—liver cancer	0.000425	0.00169	CcSEcCtD
Clarithromycin—Infestation—Doxorubicin—liver cancer	0.000425	0.00169	CcSEcCtD
Clarithromycin—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000421	0.00167	CcSEcCtD
Clarithromycin—Renal failure—Doxorubicin—liver cancer	0.000417	0.00166	CcSEcCtD
Clarithromycin—Haemoglobin—Epirubicin—liver cancer	0.000414	0.00165	CcSEcCtD
Clarithromycin—Jaundice—Doxorubicin—liver cancer	0.000414	0.00165	CcSEcCtD
Clarithromycin—Stomatitis—Doxorubicin—liver cancer	0.000414	0.00165	CcSEcCtD
Clarithromycin—Rhinitis—Epirubicin—liver cancer	0.000413	0.00164	CcSEcCtD
Clarithromycin—Conjunctivitis—Doxorubicin—liver cancer	0.000413	0.00164	CcSEcCtD
Clarithromycin—Haemorrhage—Epirubicin—liver cancer	0.000412	0.00164	CcSEcCtD
Clarithromycin—Hepatitis—Epirubicin—liver cancer	0.000412	0.00164	CcSEcCtD
Clarithromycin—Pharyngitis—Epirubicin—liver cancer	0.000409	0.00163	CcSEcCtD
Clarithromycin—Urinary tract disorder—Epirubicin—liver cancer	0.000407	0.00162	CcSEcCtD
Clarithromycin—Haematuria—Doxorubicin—liver cancer	0.000405	0.00161	CcSEcCtD
Clarithromycin—Connective tissue disorder—Epirubicin—liver cancer	0.000405	0.00161	CcSEcCtD
Clarithromycin—Urethral disorder—Epirubicin—liver cancer	0.000404	0.00161	CcSEcCtD
Clarithromycin—Hepatobiliary disease—Doxorubicin—liver cancer	0.000402	0.0016	CcSEcCtD
Clarithromycin—Epistaxis—Doxorubicin—liver cancer	0.0004	0.00159	CcSEcCtD
Clarithromycin—Visual impairment—Epirubicin—liver cancer	0.000397	0.00158	CcSEcCtD
Clarithromycin—Agranulocytosis—Doxorubicin—liver cancer	0.000396	0.00158	CcSEcCtD
Clarithromycin—Erythema multiforme—Epirubicin—liver cancer	0.000389	0.00155	CcSEcCtD
Clarithromycin—Eye disorder—Epirubicin—liver cancer	0.000385	0.00153	CcSEcCtD
Clarithromycin—Tinnitus—Epirubicin—liver cancer	0.000384	0.00153	CcSEcCtD
Clarithromycin—Haemoglobin—Doxorubicin—liver cancer	0.000383	0.00152	CcSEcCtD
Clarithromycin—Cardiac disorder—Epirubicin—liver cancer	0.000382	0.00152	CcSEcCtD
Clarithromycin—Flushing—Epirubicin—liver cancer	0.000382	0.00152	CcSEcCtD
Clarithromycin—Rhinitis—Doxorubicin—liver cancer	0.000382	0.00152	CcSEcCtD
Clarithromycin—Haemorrhage—Doxorubicin—liver cancer	0.000381	0.00152	CcSEcCtD
Clarithromycin—Hepatitis—Doxorubicin—liver cancer	0.000381	0.00152	CcSEcCtD
Clarithromycin—Pharyngitis—Doxorubicin—liver cancer	0.000378	0.00151	CcSEcCtD
Clarithromycin—Urinary tract disorder—Doxorubicin—liver cancer	0.000376	0.0015	CcSEcCtD
Clarithromycin—Connective tissue disorder—Doxorubicin—liver cancer	0.000375	0.00149	CcSEcCtD
Clarithromycin—Angiopathy—Epirubicin—liver cancer	0.000374	0.00149	CcSEcCtD
Clarithromycin—Urethral disorder—Doxorubicin—liver cancer	0.000374	0.00149	CcSEcCtD
Clarithromycin—Immune system disorder—Epirubicin—liver cancer	0.000372	0.00148	CcSEcCtD
Clarithromycin—Mediastinal disorder—Epirubicin—liver cancer	0.000371	0.00148	CcSEcCtD
Clarithromycin—Chills—Epirubicin—liver cancer	0.00037	0.00147	CcSEcCtD
Clarithromycin—Visual impairment—Doxorubicin—liver cancer	0.000367	0.00146	CcSEcCtD
Clarithromycin—Mental disorder—Epirubicin—liver cancer	0.000361	0.00144	CcSEcCtD
Clarithromycin—Erythema multiforme—Doxorubicin—liver cancer	0.00036	0.00143	CcSEcCtD
Clarithromycin—Malnutrition—Epirubicin—liver cancer	0.000359	0.00143	CcSEcCtD
Clarithromycin—Eye disorder—Doxorubicin—liver cancer	0.000356	0.00142	CcSEcCtD
Clarithromycin—Tinnitus—Doxorubicin—liver cancer	0.000355	0.00141	CcSEcCtD
Clarithromycin—Flushing—Doxorubicin—liver cancer	0.000354	0.00141	CcSEcCtD
Clarithromycin—Cardiac disorder—Doxorubicin—liver cancer	0.000354	0.00141	CcSEcCtD
Clarithromycin—Flatulence—Epirubicin—liver cancer	0.000353	0.00141	CcSEcCtD
Clarithromycin—Tension—Epirubicin—liver cancer	0.000352	0.0014	CcSEcCtD
Clarithromycin—Dysgeusia—Epirubicin—liver cancer	0.000351	0.0014	CcSEcCtD
Clarithromycin—Nervousness—Epirubicin—liver cancer	0.000348	0.00139	CcSEcCtD
Clarithromycin—Back pain—Epirubicin—liver cancer	0.000347	0.00138	CcSEcCtD
Clarithromycin—Angiopathy—Doxorubicin—liver cancer	0.000346	0.00138	CcSEcCtD
Clarithromycin—Muscle spasms—Epirubicin—liver cancer	0.000345	0.00137	CcSEcCtD
Clarithromycin—Immune system disorder—Doxorubicin—liver cancer	0.000344	0.00137	CcSEcCtD
Clarithromycin—Mediastinal disorder—Doxorubicin—liver cancer	0.000343	0.00137	CcSEcCtD
Clarithromycin—Chills—Doxorubicin—liver cancer	0.000342	0.00136	CcSEcCtD
Clarithromycin—Mental disorder—Doxorubicin—liver cancer	0.000334	0.00133	CcSEcCtD
Clarithromycin—Ill-defined disorder—Epirubicin—liver cancer	0.000333	0.00132	CcSEcCtD
Clarithromycin—Malnutrition—Doxorubicin—liver cancer	0.000332	0.00132	CcSEcCtD
Clarithromycin—Anaemia—Epirubicin—liver cancer	0.000331	0.00132	CcSEcCtD
Clarithromycin—Agitation—Epirubicin—liver cancer	0.00033	0.00131	CcSEcCtD
Clarithromycin—Flatulence—Doxorubicin—liver cancer	0.000327	0.0013	CcSEcCtD
Clarithromycin—Tension—Doxorubicin—liver cancer	0.000326	0.0013	CcSEcCtD
Clarithromycin—Dysgeusia—Doxorubicin—liver cancer	0.000325	0.00129	CcSEcCtD
Clarithromycin—Malaise—Epirubicin—liver cancer	0.000323	0.00129	CcSEcCtD
Clarithromycin—Nervousness—Doxorubicin—liver cancer	0.000322	0.00128	CcSEcCtD
Clarithromycin—Vertigo—Epirubicin—liver cancer	0.000322	0.00128	CcSEcCtD
Clarithromycin—Leukopenia—Epirubicin—liver cancer	0.000321	0.00128	CcSEcCtD
Clarithromycin—Back pain—Doxorubicin—liver cancer	0.000321	0.00128	CcSEcCtD
Clarithromycin—Muscle spasms—Doxorubicin—liver cancer	0.000319	0.00127	CcSEcCtD
Clarithromycin—Palpitations—Epirubicin—liver cancer	0.000317	0.00126	CcSEcCtD
Clarithromycin—Loss of consciousness—Epirubicin—liver cancer	0.000315	0.00125	CcSEcCtD
Clarithromycin—Cough—Epirubicin—liver cancer	0.000313	0.00125	CcSEcCtD
Clarithromycin—Convulsion—Epirubicin—liver cancer	0.000311	0.00124	CcSEcCtD
Clarithromycin—Ill-defined disorder—Doxorubicin—liver cancer	0.000308	0.00122	CcSEcCtD
Clarithromycin—Anaemia—Doxorubicin—liver cancer	0.000307	0.00122	CcSEcCtD
Clarithromycin—Myalgia—Epirubicin—liver cancer	0.000305	0.00121	CcSEcCtD
Clarithromycin—Chest pain—Epirubicin—liver cancer	0.000305	0.00121	CcSEcCtD
Clarithromycin—Agitation—Doxorubicin—liver cancer	0.000305	0.00121	CcSEcCtD
Clarithromycin—Anxiety—Epirubicin—liver cancer	0.000304	0.00121	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000303	0.00121	CcSEcCtD
Clarithromycin—Discomfort—Epirubicin—liver cancer	0.000302	0.0012	CcSEcCtD
Clarithromycin—Malaise—Doxorubicin—liver cancer	0.000299	0.00119	CcSEcCtD
Clarithromycin—Dry mouth—Epirubicin—liver cancer	0.000299	0.00119	CcSEcCtD
Clarithromycin—Vertigo—Doxorubicin—liver cancer	0.000298	0.00119	CcSEcCtD
Clarithromycin—Leukopenia—Doxorubicin—liver cancer	0.000297	0.00118	CcSEcCtD
Clarithromycin—Confusional state—Epirubicin—liver cancer	0.000295	0.00117	CcSEcCtD
Clarithromycin—Palpitations—Doxorubicin—liver cancer	0.000293	0.00117	CcSEcCtD
Clarithromycin—Anaphylactic shock—Epirubicin—liver cancer	0.000293	0.00116	CcSEcCtD
Clarithromycin—Loss of consciousness—Doxorubicin—liver cancer	0.000292	0.00116	CcSEcCtD
Clarithromycin—Infection—Epirubicin—liver cancer	0.000291	0.00116	CcSEcCtD
Clarithromycin—Cough—Doxorubicin—liver cancer	0.00029	0.00115	CcSEcCtD
Clarithromycin—Convulsion—Doxorubicin—liver cancer	0.000287	0.00114	CcSEcCtD
Clarithromycin—Nervous system disorder—Epirubicin—liver cancer	0.000287	0.00114	CcSEcCtD
Clarithromycin—Thrombocytopenia—Epirubicin—liver cancer	0.000287	0.00114	CcSEcCtD
Clarithromycin—Skin disorder—Epirubicin—liver cancer	0.000284	0.00113	CcSEcCtD
Clarithromycin—Hyperhidrosis—Epirubicin—liver cancer	0.000283	0.00113	CcSEcCtD
Clarithromycin—Myalgia—Doxorubicin—liver cancer	0.000282	0.00112	CcSEcCtD
Clarithromycin—Chest pain—Doxorubicin—liver cancer	0.000282	0.00112	CcSEcCtD
Clarithromycin—Anxiety—Doxorubicin—liver cancer	0.000281	0.00112	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000281	0.00112	CcSEcCtD
Clarithromycin—Discomfort—Doxorubicin—liver cancer	0.000279	0.00111	CcSEcCtD
Clarithromycin—Anorexia—Epirubicin—liver cancer	0.000279	0.00111	CcSEcCtD
Clarithromycin—Dry mouth—Doxorubicin—liver cancer	0.000276	0.0011	CcSEcCtD
Clarithromycin—Confusional state—Doxorubicin—liver cancer	0.000273	0.00109	CcSEcCtD
Clarithromycin—Anaphylactic shock—Doxorubicin—liver cancer	0.000271	0.00108	CcSEcCtD
Clarithromycin—Infection—Doxorubicin—liver cancer	0.000269	0.00107	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000267	0.00106	CcSEcCtD
Clarithromycin—Nervous system disorder—Doxorubicin—liver cancer	0.000266	0.00106	CcSEcCtD
Clarithromycin—Thrombocytopenia—Doxorubicin—liver cancer	0.000265	0.00105	CcSEcCtD
Clarithromycin—Insomnia—Epirubicin—liver cancer	0.000265	0.00105	CcSEcCtD
Clarithromycin—Skin disorder—Doxorubicin—liver cancer	0.000263	0.00105	CcSEcCtD
Clarithromycin—Paraesthesia—Epirubicin—liver cancer	0.000263	0.00105	CcSEcCtD
Clarithromycin—Hyperhidrosis—Doxorubicin—liver cancer	0.000262	0.00104	CcSEcCtD
Clarithromycin—Dyspnoea—Epirubicin—liver cancer	0.000261	0.00104	CcSEcCtD
Clarithromycin—Somnolence—Epirubicin—liver cancer	0.00026	0.00104	CcSEcCtD
Clarithromycin—Anorexia—Doxorubicin—liver cancer	0.000258	0.00103	CcSEcCtD
Clarithromycin—Dyspepsia—Epirubicin—liver cancer	0.000258	0.00103	CcSEcCtD
Clarithromycin—Decreased appetite—Epirubicin—liver cancer	0.000254	0.00101	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Epirubicin—liver cancer	0.000253	0.00101	CcSEcCtD
Clarithromycin—Fatigue—Epirubicin—liver cancer	0.000252	0.001	CcSEcCtD
Clarithromycin—Constipation—Epirubicin—liver cancer	0.00025	0.000996	CcSEcCtD
Clarithromycin—Pain—Epirubicin—liver cancer	0.00025	0.000996	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000247	0.000982	CcSEcCtD
Clarithromycin—Insomnia—Doxorubicin—liver cancer	0.000245	0.000975	CcSEcCtD
Clarithromycin—Paraesthesia—Doxorubicin—liver cancer	0.000243	0.000967	CcSEcCtD
Clarithromycin—Dyspnoea—Doxorubicin—liver cancer	0.000241	0.000961	CcSEcCtD
Clarithromycin—Feeling abnormal—Epirubicin—liver cancer	0.000241	0.00096	CcSEcCtD
Clarithromycin—Somnolence—Doxorubicin—liver cancer	0.000241	0.000958	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Epirubicin—liver cancer	0.000239	0.000952	CcSEcCtD
Clarithromycin—Dyspepsia—Doxorubicin—liver cancer	0.000238	0.000948	CcSEcCtD
Clarithromycin—Decreased appetite—Doxorubicin—liver cancer	0.000235	0.000937	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000234	0.00093	CcSEcCtD
Clarithromycin—Fatigue—Doxorubicin—liver cancer	0.000233	0.000929	CcSEcCtD
Clarithromycin—Urticaria—Epirubicin—liver cancer	0.000232	0.000925	CcSEcCtD
Clarithromycin—Pain—Doxorubicin—liver cancer	0.000232	0.000921	CcSEcCtD
Clarithromycin—Constipation—Doxorubicin—liver cancer	0.000232	0.000921	CcSEcCtD
Clarithromycin—Body temperature increased—Epirubicin—liver cancer	0.000231	0.000921	CcSEcCtD
Clarithromycin—Abdominal pain—Epirubicin—liver cancer	0.000231	0.000921	CcSEcCtD
Clarithromycin—Feeling abnormal—Doxorubicin—liver cancer	0.000223	0.000888	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Doxorubicin—liver cancer	0.000221	0.000881	CcSEcCtD
Clarithromycin—Hypersensitivity—Epirubicin—liver cancer	0.000216	0.000858	CcSEcCtD
Clarithromycin—Urticaria—Doxorubicin—liver cancer	0.000215	0.000856	CcSEcCtD
Clarithromycin—Abdominal pain—Doxorubicin—liver cancer	0.000214	0.000852	CcSEcCtD
Clarithromycin—Body temperature increased—Doxorubicin—liver cancer	0.000214	0.000852	CcSEcCtD
Clarithromycin—Asthenia—Epirubicin—liver cancer	0.00021	0.000835	CcSEcCtD
Clarithromycin—Pruritus—Epirubicin—liver cancer	0.000207	0.000824	CcSEcCtD
Clarithromycin—Diarrhoea—Epirubicin—liver cancer	0.0002	0.000797	CcSEcCtD
Clarithromycin—Hypersensitivity—Doxorubicin—liver cancer	0.000199	0.000794	CcSEcCtD
Clarithromycin—Asthenia—Doxorubicin—liver cancer	0.000194	0.000773	CcSEcCtD
Clarithromycin—Dizziness—Epirubicin—liver cancer	0.000194	0.00077	CcSEcCtD
Clarithromycin—Pruritus—Doxorubicin—liver cancer	0.000192	0.000762	CcSEcCtD
Clarithromycin—Vomiting—Epirubicin—liver cancer	0.000186	0.00074	CcSEcCtD
Clarithromycin—Diarrhoea—Doxorubicin—liver cancer	0.000185	0.000737	CcSEcCtD
Clarithromycin—Rash—Epirubicin—liver cancer	0.000185	0.000734	CcSEcCtD
Clarithromycin—Dermatitis—Epirubicin—liver cancer	0.000184	0.000734	CcSEcCtD
Clarithromycin—Headache—Epirubicin—liver cancer	0.000183	0.000729	CcSEcCtD
Clarithromycin—Dizziness—Doxorubicin—liver cancer	0.000179	0.000712	CcSEcCtD
Clarithromycin—Nausea—Epirubicin—liver cancer	0.000174	0.000692	CcSEcCtD
Clarithromycin—Vomiting—Doxorubicin—liver cancer	0.000172	0.000685	CcSEcCtD
Clarithromycin—Rash—Doxorubicin—liver cancer	0.000171	0.000679	CcSEcCtD
Clarithromycin—Dermatitis—Doxorubicin—liver cancer	0.000171	0.000679	CcSEcCtD
Clarithromycin—Headache—Doxorubicin—liver cancer	0.00017	0.000675	CcSEcCtD
Clarithromycin—Nausea—Doxorubicin—liver cancer	0.000161	0.00064	CcSEcCtD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK14—liver cancer	6.48e-05	0.00059	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—liver cancer	6.48e-05	0.00059	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	6.41e-05	0.000584	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—UGDH—liver cancer	6.4e-05	0.000582	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—liver cancer	6.36e-05	0.000579	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—TNF—liver cancer	6.24e-05	0.000568	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—UGDH—liver cancer	6.24e-05	0.000568	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—EPT1—liver cancer	6.01e-05	0.000547	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—liver cancer	6.01e-05	0.000547	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—GSTA4—liver cancer	6.01e-05	0.000547	CbGpPWpGaD
Clarithromycin—CYP3A4—Biological oxidations—GSTP1—liver cancer	5.9e-05	0.000537	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—EPT1—liver cancer	5.87e-05	0.000534	CbGpPWpGaD
Clarithromycin—SLC22A7—Transmembrane transport of small molecules—RAF1—liver cancer	5.86e-05	0.000534	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—GSTA2—liver cancer	5.86e-05	0.000533	CbGpPWpGaD
Clarithromycin—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	5.82e-05	0.00053	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—TAT—liver cancer	5.7e-05	0.000519	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—GSTA1—liver cancer	5.65e-05	0.000515	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	5.61e-05	0.00051	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—NAT2—liver cancer	5.59e-05	0.000509	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—TAT—liver cancer	5.56e-05	0.000507	CbGpPWpGaD
Clarithromycin—CYP3A4—Biological oxidations—GSTM1—liver cancer	5.42e-05	0.000494	CbGpPWpGaD
Clarithromycin—ABCB1—HIF-1-alpha transcription factor network—AKT1—liver cancer	5.37e-05	0.000489	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—ALDOB—liver cancer	5.36e-05	0.000488	CbGpPWpGaD
Clarithromycin—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	5.35e-05	0.000487	CbGpPWpGaD
Clarithromycin—CYP3A4—Biological oxidations—CYP1A1—liver cancer	5.14e-05	0.000468	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—CRABP1—liver cancer	5.11e-05	0.000465	CbGpPWpGaD
Clarithromycin—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	5.07e-05	0.000462	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—GLUL—liver cancer	5.01e-05	0.000456	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—CPT1B—liver cancer	5.01e-05	0.000456	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	5e-05	0.000455	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—UGDH—liver cancer	4.98e-05	0.000454	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—NR1H4—liver cancer	4.83e-05	0.00044	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—GSTA3—liver cancer	4.75e-05	0.000433	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	4.72e-05	0.00043	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—EPT1—liver cancer	4.68e-05	0.000427	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—HPGDS—liver cancer	4.47e-05	0.000407	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—TAT—liver cancer	4.44e-05	0.000404	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	4.37e-05	0.000398	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—GSTA4—liver cancer	4.35e-05	0.000396	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	4.32e-05	0.000394	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	4.24e-05	0.000386	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—GSTA2—liver cancer	4.23e-05	0.000386	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—liver cancer	4.2e-05	0.000382	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	4.12e-05	0.000375	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	4.12e-05	0.000375	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—GSTA1—liver cancer	4.09e-05	0.000372	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	4.08e-05	0.000372	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—NAT2—liver cancer	4.04e-05	0.000368	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	3.99e-05	0.000363	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—PSMA4—liver cancer	3.98e-05	0.000363	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—PSMD10—liver cancer	3.98e-05	0.000363	CbGpPWpGaD
Clarithromycin—ABCB1—Transmembrane transport of small molecules—CYCS—liver cancer	3.97e-05	0.000361	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	3.89e-05	0.000355	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—GLUL—liver cancer	3.87e-05	0.000353	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—CPT1B—liver cancer	3.87e-05	0.000353	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—GOT2—liver cancer	3.87e-05	0.000353	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—ALDOB—liver cancer	3.87e-05	0.000353	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—UGDH—liver cancer	3.85e-05	0.00035	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—GLUL—liver cancer	3.78e-05	0.000344	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—CPT1B—liver cancer	3.78e-05	0.000344	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—NR1H4—liver cancer	3.74e-05	0.00034	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—CRABP1—liver cancer	3.69e-05	0.000336	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—GSTA3—liver cancer	3.67e-05	0.000334	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—NR1H4—liver cancer	3.65e-05	0.000332	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—CYP2E1—liver cancer	3.64e-05	0.000332	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—EPT1—liver cancer	3.62e-05	0.000329	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	3.6e-05	0.000327	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—GSTA3—liver cancer	3.59e-05	0.000326	CbGpPWpGaD
Clarithromycin—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	3.45e-05	0.000314	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—TAT—liver cancer	3.43e-05	0.000312	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—CYCS—liver cancer	3.41e-05	0.00031	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—GSTA4—liver cancer	3.36e-05	0.000306	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—GOT1—liver cancer	3.34e-05	0.000304	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—GGT1—liver cancer	3.34e-05	0.000304	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	3.31e-05	0.000301	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	3.3e-05	0.0003	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	3.28e-05	0.000299	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—GSTA4—liver cancer	3.28e-05	0.000299	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—GSTA2—liver cancer	3.27e-05	0.000298	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	3.27e-05	0.000298	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—HPGDS—liver cancer	3.23e-05	0.000294	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—GSTA2—liver cancer	3.2e-05	0.000291	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—GSTA1—liver cancer	3.16e-05	0.000288	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—NAT2—liver cancer	3.12e-05	0.000284	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—GSTA1—liver cancer	3.08e-05	0.000281	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	3.08e-05	0.000281	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	3.06e-05	0.000278	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—NAT2—liver cancer	3.05e-05	0.000278	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—GLUL—liver cancer	3.02e-05	0.000275	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—CPT1B—liver cancer	3.02e-05	0.000275	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—GSTP1—liver cancer	3e-05	0.000273	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—liver cancer	3e-05	0.000273	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—ALDOB—liver cancer	2.99e-05	0.000273	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—HMOX1—liver cancer	2.96e-05	0.00027	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—ALDOB—liver cancer	2.92e-05	0.000266	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—NR1H4—liver cancer	2.91e-05	0.000265	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—PSMA4—liver cancer	2.88e-05	0.000262	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—PSMD10—liver cancer	2.88e-05	0.000262	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—GSTA3—liver cancer	2.86e-05	0.000261	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—CRABP1—liver cancer	2.86e-05	0.00026	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	2.81e-05	0.000256	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—GOT2—liver cancer	2.8e-05	0.000255	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—CRABP1—liver cancer	2.79e-05	0.000254	CbGpPWpGaD
Clarithromycin—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	2.79e-05	0.000254	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—GSTM1—liver cancer	2.76e-05	0.000251	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	2.72e-05	0.000247	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—CYP2E1—liver cancer	2.63e-05	0.00024	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—GSTA4—liver cancer	2.62e-05	0.000238	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—CYP1A1—liver cancer	2.62e-05	0.000238	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.57e-05	0.000234	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.56e-05	0.000233	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—GSTA2—liver cancer	2.55e-05	0.000232	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—HPGDS—liver cancer	2.5e-05	0.000227	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.48e-05	0.000226	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—CYCS—liver cancer	2.46e-05	0.000224	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—GSTA1—liver cancer	2.46e-05	0.000224	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—MTHFR—liver cancer	2.44e-05	0.000222	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—HPGDS—liver cancer	2.44e-05	0.000222	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—NAT2—liver cancer	2.43e-05	0.000222	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—GOT1—liver cancer	2.42e-05	0.00022	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—GGT1—liver cancer	2.42e-05	0.00022	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—PPARA—liver cancer	2.39e-05	0.000218	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.34e-05	0.000213	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—ALDOB—liver cancer	2.33e-05	0.000212	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—CPT1B—liver cancer	2.33e-05	0.000212	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—GLUL—liver cancer	2.33e-05	0.000212	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	2.29e-05	0.000209	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.26e-05	0.000206	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—NR1H4—liver cancer	2.25e-05	0.000205	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.23e-05	0.000203	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—CRABP1—liver cancer	2.23e-05	0.000203	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—PSMA4—liver cancer	2.23e-05	0.000203	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—PSMD10—liver cancer	2.23e-05	0.000203	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—GSTA3—liver cancer	2.21e-05	0.000201	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—PSMD10—liver cancer	2.17e-05	0.000198	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—PSMA4—liver cancer	2.17e-05	0.000198	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—GSTP1—liver cancer	2.17e-05	0.000198	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—GOT2—liver cancer	2.16e-05	0.000197	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—HMOX1—liver cancer	2.14e-05	0.000195	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—GOT2—liver cancer	2.11e-05	0.000192	CbGpPWpGaD
Clarithromycin—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	2.07e-05	0.000189	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—PIK3CG—liver cancer	2.05e-05	0.000187	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—CYP2E1—liver cancer	2.04e-05	0.000185	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—GSTA4—liver cancer	2.02e-05	0.000184	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2e-05	0.000182	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—GSTM1—liver cancer	2e-05	0.000182	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—CYP2E1—liver cancer	1.99e-05	0.000181	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—PPARG—liver cancer	1.98e-05	0.00018	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.97e-05	0.000179	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—GSTA2—liver cancer	1.97e-05	0.000179	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—HPGDS—liver cancer	1.95e-05	0.000177	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.93e-05	0.000176	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—CYCS—liver cancer	1.9e-05	0.000173	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—GSTA1—liver cancer	1.9e-05	0.000173	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—CYP1A1—liver cancer	1.89e-05	0.000172	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—NAT2—liver cancer	1.88e-05	0.000171	CbGpPWpGaD
Clarithromycin—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	1.87e-05	0.000171	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—GGT1—liver cancer	1.87e-05	0.00017	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—GOT1—liver cancer	1.87e-05	0.00017	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—CYCS—liver cancer	1.86e-05	0.000169	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—GOT1—liver cancer	1.82e-05	0.000166	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—GGT1—liver cancer	1.82e-05	0.000166	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—PIK3CD—liver cancer	1.8e-05	0.000164	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—ALDOB—liver cancer	1.8e-05	0.000164	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—ALB—liver cancer	1.78e-05	0.000162	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—MTHFR—liver cancer	1.76e-05	0.000161	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.76e-05	0.00016	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.74e-05	0.000158	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—PSMA4—liver cancer	1.73e-05	0.000158	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—PSMD10—liver cancer	1.73e-05	0.000158	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—PPARA—liver cancer	1.73e-05	0.000158	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—CRABP1—liver cancer	1.72e-05	0.000156	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—GOT2—liver cancer	1.69e-05	0.000154	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—GSTP1—liver cancer	1.68e-05	0.000153	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—HMOX1—liver cancer	1.66e-05	0.000151	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—GSTP1—liver cancer	1.64e-05	0.000149	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—HMOX1—liver cancer	1.62e-05	0.000147	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—CYP2E1—liver cancer	1.59e-05	0.000144	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—PIK3CB—liver cancer	1.57e-05	0.000143	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—GSTM1—liver cancer	1.54e-05	0.00014	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.54e-05	0.00014	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—GSTM1—liver cancer	1.51e-05	0.000137	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—HPGDS—liver cancer	1.5e-05	0.000137	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—CYCS—liver cancer	1.48e-05	0.000135	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—PIK3CG—liver cancer	1.48e-05	0.000135	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—CYP1A1—liver cancer	1.46e-05	0.000133	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—GGT1—liver cancer	1.46e-05	0.000133	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—GOT1—liver cancer	1.46e-05	0.000133	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—PPARG—liver cancer	1.43e-05	0.00013	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—CYP1A1—liver cancer	1.43e-05	0.00013	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—MTHFR—liver cancer	1.36e-05	0.000124	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—PSMA4—liver cancer	1.34e-05	0.000122	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—PSMD10—liver cancer	1.34e-05	0.000122	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—PPARA—liver cancer	1.34e-05	0.000122	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—MTHFR—liver cancer	1.33e-05	0.000121	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—GSTP1—liver cancer	1.31e-05	0.000119	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—PPARA—liver cancer	1.31e-05	0.000119	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—PIK3CD—liver cancer	1.3e-05	0.000119	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—GOT2—liver cancer	1.3e-05	0.000119	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—HMOX1—liver cancer	1.29e-05	0.000117	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—ALB—liver cancer	1.29e-05	0.000117	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—CYP2E1—liver cancer	1.22e-05	0.000111	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—GSTM1—liver cancer	1.2e-05	0.000109	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.2e-05	0.000109	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—PIK3CG—liver cancer	1.15e-05	0.000104	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—CYCS—liver cancer	1.15e-05	0.000104	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—CYP1A1—liver cancer	1.14e-05	0.000104	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—PIK3CB—liver cancer	1.14e-05	0.000103	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—GGT1—liver cancer	1.12e-05	0.000102	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—GOT1—liver cancer	1.12e-05	0.000102	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—PIK3CG—liver cancer	1.12e-05	0.000102	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—PPARG—liver cancer	1.11e-05	0.000101	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—PPARG—liver cancer	1.08e-05	9.82e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—MTHFR—liver cancer	1.06e-05	9.67e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—PPARA—liver cancer	1.04e-05	9.49e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—GSTP1—liver cancer	1.01e-05	9.19e-05	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—PIK3CD—liver cancer	1.01e-05	9.17e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—HMOX1—liver cancer	9.95e-06	9.06e-05	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—ALB—liver cancer	9.94e-06	9.05e-05	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—PIK3CD—liver cancer	9.83e-06	8.95e-05	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—ALB—liver cancer	9.7e-06	8.83e-05	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—PIK3CA—liver cancer	9.57e-06	8.72e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	9.36e-06	8.52e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—GSTM1—liver cancer	9.28e-06	8.45e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—PIK3CG—liver cancer	8.92e-06	8.13e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—CYP1A1—liver cancer	8.79e-06	8.01e-05	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—PIK3CB—liver cancer	8.78e-06	7.99e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—PPARG—liver cancer	8.61e-06	7.84e-05	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—PIK3CB—liver cancer	8.57e-06	7.8e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—MTHFR—liver cancer	8.2e-06	7.46e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—PPARA—liver cancer	8.04e-06	7.32e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—PIK3CD—liver cancer	7.85e-06	7.14e-05	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—AKT1—liver cancer	7.82e-06	7.12e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—ALB—liver cancer	7.74e-06	7.05e-05	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—PIK3CA—liver cancer	6.92e-06	6.3e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—PIK3CG—liver cancer	6.89e-06	6.27e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—PIK3CB—liver cancer	6.84e-06	6.23e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—PPARG—liver cancer	6.65e-06	6.05e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—PIK3CD—liver cancer	6.05e-06	5.51e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—ALB—liver cancer	5.98e-06	5.44e-05	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—AKT1—liver cancer	5.65e-06	5.15e-05	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—PIK3CA—liver cancer	5.35e-06	4.87e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—PIK3CB—liver cancer	5.28e-06	4.81e-05	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—PIK3CA—liver cancer	5.22e-06	4.75e-05	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—AKT1—liver cancer	4.37e-06	3.98e-05	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—AKT1—liver cancer	4.27e-06	3.88e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—PIK3CA—liver cancer	4.17e-06	3.8e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—AKT1—liver cancer	3.41e-06	3.1e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—PIK3CA—liver cancer	3.22e-06	2.93e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—AKT1—liver cancer	2.63e-06	2.39e-05	CbGpPWpGaD
